Hygea VCT
17
1M
15
0.74
5
0.12
6
- Stages of investment
- Areas of investment
Summary
Hygea VCT appeared to be the VC, which was created in 2001. The leading representative office of defined VC is situated in the Brackley. The fund was located in Europe if to be more exact in United Kingdom.
Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this Hygea VCT performs on 9 percentage points more the average number of lead investments. The top activity for fund was in 2010. The top amount of exits for fund were in 2010. The common things for fund are deals in the range of 1 - 5 millions dollars.
The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Purely Proteins Limited, ImmunoBiology Ltd, Scancell.
Besides them, we counted 1 critical employee of this fund in our database.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Hygea VCT, startups are often financed by Oxford Technology Management, Oxford Capital Partners, Entrepreneurs Fund. The meaningful sponsors for the fund in investment in the same round are Oxford Capital Partners, Oxford Technology Management, MTI. In the next rounds fund is usually obtained by Oxford Capital Partners, Parkwalk Advisors, MTI.
Investments analytics
Analytics
- Total investments
- 17
- Lead investments
- 5
- Exits
- 6
- Rounds per year
- 0.74
- Follow on index
- 0.12
- Investments by industry
- Biotechnology (11)
- Health Care (8)
- Pharmaceutical (4)
- Health Diagnostics (3)
- Medical Device (3) Show 18 more
- Investments by region
-
- United Kingdom (14)
- United States (2)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 14M
- Group Appearance index
- 0.53
- Avg. company exit year
- 13
- Avg. multiplicator
- 57.79
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Purely Proteins Limited | 01 Dec 2004 | Biotechnology | Early Stage Venture | 3M | Cambridge, United Kingdom, England |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.